We have over 50 years’ experience in the pharmaceutical contract packaging sector with significant capabilities and expertise in the commercial packaging of biologics and biosimilars.
Due to these markets being driven by innovation and a trend towards self-administration and patient-centricity, we offer a comprehensive service for injectable drug delivery device packaging.
Biologic medicines require considerably different forms of drug delivery compared to traditional medications. PCI provides expanded biotech packaging capabilities across our global network, in addition to our expanded Cold Chain infrastructure.
PCI’s injectable assembly, labeling and delivery form capabilities include:
- Standard prefilled syringes
- Advanced safety syringes
- Pen devices